EBV-linked killer T cells implicated in multiple sclerosis
Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to…
Immune scaffold predicts onset weeks early
A retrievable immune scaffold reveals a 5–7 week presymptomatic window for tracking type 1 diabetes progression, long before…
Research uncovers alternative inflammatory pathway in rheumatoid arthritis treatment
The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but…
Girl, 9, Becomes Different Person Overnight, Mom Fights For Rare Diagnosis
Lacy was an outgoing, fun nine-year-old. Then, one night, everything changed. She became a shell of herself. Her…
Reprogramming camp for immune cells shows early promise for autoimmune diseases
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune…
Scientists map the genetic control system behind FOXP3 in immune cells
The immune system faces a delicate balancing act: it must be aggressive enough to fight infections and cancer,…
Scripps Research professor wins $3.2 million grant to unravel the mysteries of type 1 diabetes
Luc Teyton, professor in the Department of Immunology and Microbiology at Scripps Research, has received a five-year, $3.2…